Cellectis CLLS
NASDAQ CLLS
$1.38 +0.27 (+24.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Cellectis (CLLS) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Cellectis' Return on Capital Employed [ROCE] came in at -21.42% for Q2 2026, up 2.18 percentage points from -23.60% a year earlier but down 6.64 percentage points from the prior quarter.

Analysis

Cellectis (CLLS) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Cellectis' Return on Capital Employed [ROCE] was -9.62%, up 7.75 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +0.73 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -17.37% in FY2024 (+15.90 pp), -33.27% in FY2023 (-4.95 pp), -28.33% in FY2022 (-3.89 pp) and -24.44% in FY2021 (-14.08 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -44.29% (Q2 2022) to -7.99% (Q3 2025).
  • Year-over-year, Return on Capital Employed [ROCE] has increased for ten consecutive quarters, with an average year-over-year change of +11.49 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2024 (a gain of 22.19 percentage points), and the weakest in Q2 2022 (a drop of 32.36 percentage points).
  • Business Quant data shows CLLS's Return on Capital Employed [ROCE] at -14.78% (Q1 2026), -10.23% (Q4 2025) and -7.99% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Cellectis 111.38 Mn -642.02 Mn - -40.47%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.47%
Mar 31, 2026 -25.55%
Dec 31, 2025 -17.58%
Sep 30, 2025 -13.21%
Jun 30, 2025 -23.60%
Mar 31, 2025 -25.01%
Dec 31, 2024 -26.65%
Sep 30, 2024 -33.26%
Jun 30, 2024 -39.95%
Mar 31, 2024 -50.97%
Dec 31, 2023 -83.28%
Sep 30, 2023 -42.00%
Jun 30, 2023 -40.54%
Mar 31, 2023 -39.29%
Dec 31, 2022 -40.29%
Sep 30, 2022 -43.87%
Jun 30, 2022 -44.29%
Mar 31, 2022 -42.79%
Dec 31, 2021 -35.71%
Sep 30, 2021 -36.02%
API Access

Cellectis Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CLLS&period=max&api_key=YOUR_API_KEY